Suppr超能文献

深吸气屏气-质子束治疗对心脏转移瘤的剂量学优势

Dosimetric superiority of deep inspiration breath hold-proton beam therapy for cardiac metastasis.

作者信息

Chen Dong-Jie, Zhao Man, Lu Jia-Wei, Sun Han, Jiang Wei, Liang Jun

机构信息

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China.

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China.

出版信息

Med Dosim. 2025;50(3):246-252. doi: 10.1016/j.meddos.2025.02.005. Epub 2025 Mar 28.

Abstract

The purpose of this case report is to compare the dosimetric disparities between photon radiotherapy and intensity-modulated proton therapy (IMPT) with or without deep inspiration breath hold (DIBH) for cardiac tumors. We present a case involving a 66-year-old female with cardiac metastasis from thymic carcinoma. A total dose of 50Gy/50Gy in 25 fractions was administered to the cardiac metastases. Two simulation CT scans were obtained during free breath (FB) and DIBH. Dose distribution to target and organs at risk(OARs) was compared between intensity modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT) and IMPT. All of the 6 plans satisfied treatment planning goals. The coronary artery (CA) Dmean (mean dose) was 28.32 Gy for IMRT-DIBH, 42.66 Gy for IMRT-FB, 26.44 Gy for VMAT-DIBH, 40.85 Gy for VMAT-FB, 27.71 Gy for IMPT-DIBH, and 39.51 Gy for IMPT-FB. The heart V50 (volume receiving ≥50 Gy) was 3.90 Gy for IMRT-DIBH, 6.71 Gy for IMRT-FB, 4.80 Gy for VMAT-DIBH, 6.63 Gy for VMAT-FB, 0.99 Gy for IMPT-DIBH, and 6.67 Gy for IMPT-FB, respectively. DIBH resulted in dose reductions in all OARs, particularly the heart and CA, compared to FB in all 3 planning techniques (IMRT, VMAT, and IMPT). Similarly, compared with IMRT or VMAT, IMPT reduced radiation doses to most OARs, including the heart and CA, in both FB and DIBH. DIBH-IMPT demonstrated superior dose coverage and OARs sparing in this thymic carcinoma patient with cardiac metastasis. Given the anticipated reduction in toxicities, IMPT with DIBH is preferred for cardiac tumors. The potential for broader application of IMPT with DIBH in clinical practice is currently being evaluated, and further studies are needed.

摘要

本病例报告的目的是比较光子放疗与调强质子治疗(IMPT)在有或无深吸气屏气(DIBH)情况下对心脏肿瘤的剂量差异。我们报告了一例66岁女性胸腺癌心脏转移的病例。对心脏转移灶给予总量50Gy/25次、每次2Gy的照射。在自由呼吸(FB)和DIBH状态下分别进行了两次模拟CT扫描。比较了调强放疗(IMRT)、容积调强弧形放疗(VMAT)和IMPT对靶区和危及器官(OARs)的剂量分布。所有6个计划均满足治疗计划目标。冠状动脉(CA)的平均剂量(Dmean)在IMRT-DIBH时为28.32Gy,IMRT-FB时为42.66Gy,VMAT-DIBH时为26.44Gy,VMAT-FB时为40.85Gy,IMPT-DIBH时为27.71Gy,IMPT-FB时为39.51Gy。心脏V50(接受≥50Gy剂量的体积)在IMRT-DIBH时为3.90Gy,IMRT-FB时为6.71Gy,VMAT-DIBH时为4.80Gy,VMAT-FB时为6.63Gy,IMPT-DIBH时为0.99Gy,IMPT-FB时为6.67Gy。与所有3种计划技术(IMRT、VMAT和IMPT)中的FB相比,DIBH使所有OARs的剂量降低,尤其是心脏和CA。同样,与IMRT或VMAT相比,IMPT在FB和DIBH两种情况下均降低了对大多数OARs的辐射剂量,包括心脏和CA。在该例胸腺癌心脏转移患者中,DIBH-IMPT显示出更好的剂量覆盖和对OARs的保护。鉴于预期毒性降低,对于心脏肿瘤,首选DIBH联合IMPT。目前正在评估DIBH联合IMPT在临床实践中更广泛应用的潜力,还需要进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验